The World Health Organization is a valued partner across multiple engagements and initiatives. These efforts include:
Serving as a WHO Collaborating Centre for Childhood Cancer: In 2018 and again in 2022, St. Jude Children’s Research Hospital was named the World Health Organization’s first and only Collaborating Centre for Childhood Cancer. Under this designation, St. Jude supports integrating efforts to address childhood cancer into the work of WHO so more children can receive life-saving support at the national level.
Supporting the Global Initiative: In July 2018, WHO launched the Global Initiative for Childhood Cancer. This initiative’s goal: By 2030, achieve at least a 60% global survival rate for children with cancer. St. Jude serves as an implementation partner, providing subject matter expertise, assisting in developing technical tools and packages, supporting and coordinating workshops in focus countries and facilitating ongoing discussions among national and international stakeholders.
Collaborating on a New Global Medicines Platform: In December 2021, St. Jude Global and WHO announced a new approach to provide an uninterrupted supply of quality-assured cancer medicines to treat children in low- and middle-income countries.
